Hôpital Le Vinatier
Clinical trials sponsored by Hôpital Le Vinatier, explained in plain language.
-
CBD shows promise for alcohol use disorder in early trial
Disease control TerminatedThis phase 2 trial tested whether cannabidiol (CBD), a non-psychoactive compound from cannabis, could help people with alcohol use disorder reduce their drinking. The study also looked at whether CBD could protect the brain and liver from alcohol-related harm. Only 10 people were…
Phase: PHASE2 • Sponsor: Hôpital le Vinatier • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Brain zap study measures mood protein, but ends early
Knowledge-focused TerminatedThis study looked at how noninvasive brain stimulation techniques like ECT, tDCS, and rTMS change BDNF levels in people with depression or schizophrenia. Researchers took blood samples before and after stimulation to measure BDNF. The study was terminated early and did not aim to…
Phase: NA • Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:08 UTC
-
Brain and eye clues to emotion recognition in autism and psychosis
Knowledge-focused TerminatedThis study aimed to understand why people with autism or schizophrenia sometimes struggle to recognize emotions on faces. Researchers used brain wave recordings (EEG) and eye-tracking to see how participants processed facial expressions. The study included people with autism, sch…
Phase: NA • Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC